Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Endocrine 1

Conditions

Neoplasms 2Spina Bifida Occulta 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Pain, Postoperative 1Neural Tube Defects 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lipomyelomeningocele 1Cerebrospinal Fluid Leak 1

Interventions

Fulvestrant 5Exercise 5Eating 5Standard of Care 3Sodium Chloride 3Diet 3Alpelisib 3ribociclib 2gallium Ga 68 dotatate 2exemestane 2Vitamin D 2Tamoxifen 2Magnetic Resonance Spectroscopy 2Letrozole 2Ethanol 2Blood Specimen Collection 2Anastrozole 2zopiclone 1ziprasidone 1veliparib 1testosterone undecanoate 1testosterone enanthate 1pazopanib 1mirabegron 1methyl hydroxyethyl cellulose 1lenvatinib 1fluorocholine 1evolocumab 1dimethandrolone-undecanoate 1cyclopropapyrroloindole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Endocrine Neoplasia Type 1 × Acetazolamide × Clear all
NCT04470843 2022-09-23

Impact of Acetazolamide in Reducing Referred Postoperative Pain

Medical College of Wisconsin

Phase 1 Completed
33 enrolled
EndocrineGenitourinary

Pain, Postoperative, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡